ACOUSTIC PRESSURE SHOCK WAVES USED FOR PERSONALIZED MEDICAL TREATMENT OF TISSUE CONDITIONS

• US 20180221688A1
• Filed: 12/29/2017
• Published: 08/09/2018
• Est. Priority Date: 12/31/2016
• Status: Active Grant

• Current Assignee: Sanuwave, Inc. (SANUWAVE Health, Inc.)
• Original Assignee: Sanuwave, Inc. (SANUWAVE Health, Inc.)
• Inventors: Cioanta, Iulian, MCGHIN, Cary, JACKSON, John
• Granted Patent: US 10,888,715 B2
• Time in Patent Office: Days
• CPC Class Codes: A61B 18/26 for producing a shock wave, e.g. laser lithotripsy
• CPC Class Codes: A61B 2018/266 the conversion of laser energy into mechanical shockwaves taking place in a part of the probe
• CPC Class Codes: A61N 2005/063 comprising light transmitting means, e.g. optical fibres
• CPC Class Codes: A61N 2007/0017 Wound healing
• CPC Class Codes: A61N 2007/0039 using microbubbles
• CPC Class Codes: A61N 2007/006 Lenses
• CPC Class Codes: A61N 5/0616 Skin treatment other than tanning
• CPC Class Codes: A61N 5/067 using laser light
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092
• CPC Class Codes: G05B 13/026 using a predictor
• CPC Class Codes: G16H 20/40 relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
• CPC Class Codes: G16H 40/63 for local operation

Abstract

A system for individualized treatment of a tissue condition with acoustic pressure shocks includes personalized determination and automatic adjustment of a shock wave treatment regimen or shock wave dosage to be administered for personalized treatment based on factors such as a patient'"'"'s comorbidities, state of the tissue condition, individual physical characteristics and lifestyle parameters.

Claims

1. A system for treating a tissue condition of a human or animal patient comprising:

an electronic acoustic pressure shock wave applicator including a shock wave generation source enclosed within liquid by a coupling membrane;

an electronic controller coupled to the acoustic pressure shock wave applicator and including a microprocessor and a microprocessor-readable data storage medium having microprocessor-executable instructions for the microprocessor to adjust an initial treatment regimen based on the type of tissue condition and the treatment area or treatment volume, wherein the initial treatment regimen includes at least one of a number of shock waves per treatment, shock wave input energy per treatment and number of shock wave treatment sessions, to an adjusted individualized treatment regimen that changes the initial treatment regimen in response to inputs providing individualized patient parameters wherein each individualized patient parameter is selected from the group consisting of tissue condition state parameter, comorbidity parameter, physical characteristic parameter and lifestyle habit parameter of the patient, wherein said electronic controller is communicatively coupled for wireless or wired communication to the acoustic pressure shock wave applicator and causes the applicator to automatically generate the adjusted individualized treatment regimen to the patient; and

an electronic input device receiving input data in response to questions from a patient questionnaire and communicatively coupled for wireless or wired transmission of the input data to the electronic controller for determination of the individualized patient parameters and corresponding changes to the initial treatment regimen to arrive at the adjusted individualized treatment regimen.

2. The system of claim 1, wherein the individualized patient parameters are selected from the group consisting of age, medical condition, disease condition, location of the tissue condition, body mass index, weight, height, glycated hemoglobin, ankle-brachial index, transcutaneous monitoring of oxygen measurement, age of wound, bacterial load colony forming unit measurement, smoker status, alcohol consumption, steroids therapy, presence of osteomyelitis, chemotherapy or radiation therapy, immunodeficiency therapy, lung disease, and good patient compliance.

3. The system of claim 2, wherein the tissue condition is a diabetic foot ulcer.

4. The system of claim 1, wherein the tissue condition is a diabetic foot ulcer.

5. The system of claim 1, wherein the tissue condition is a skin condition.

6. The system of claim 2, wherein the tissue condition is a skin condition.

7. The system of claim 6, wherein the skin condition is selected from the group consisting of a burn, wound, pressure ulcer, arterial ulcer, and venous ulcer.

8. The system of claim 5, wherein the skin condition is selected from the group consisting of a burn, wound, pressure ulcer, arterial ulcer, and venous ulcer.

9. The system of claim 8, wherein the shock wave applicator generates acoustic pressure shock waves selected from the group consisting of focused, unfocused, planar, pseudo-planar, cylindrical, and radial extracorporeal acoustic pressure shock waves.

10. The system of claim 1, wherein the shock wave applicator generates acoustic pressure shock waves selected from the group consisting of focused, unfocused, planar, pseudo-planar, cylindrical, and radial extracorporeal acoustic pressure shock waves.

11. The system of claim 2, wherein the shock wave applicator generates acoustic pressure shock waves selected from the group consisting of focused, unfocused, planar, pseudo-planar, cylindrical, and radial extracorporeal acoustic pressure shock waves.

12. The system of claim 3, wherein the shock wave applicator generates acoustic pressure shock waves selected from the group consisting of focused, unfocused, planar, pseudo-planar, cylindrical, and radial extracorporeal acoustic pressure shock waves.

13. The system of claim 4, wherein the shock wave applicator generates acoustic pressure shock waves selected from the group consisting of focused, unfocused, planar, pseudo-planar, cylindrical, and radial extracorporeal acoustic pressure shock waves.

14. The system of claim 7, wherein the shock wave applicator generates acoustic pressure shock waves selected from the group consisting of focused, unfocused, planar, pseudo-planar, cylindrical, and radial extracorporeal acoustic pressure shock waves.

15. The system of claim 1, wherein the electronic controller is selected from the group consisting of an artificial intelligence device controller and a control console controller.

16. The system of claim 2, wherein the electronic controller is selected from the group consisting of an artificial intelligence device controller and a control console controller.

17. The system of claim 3, wherein the electronic controller is selected from the group consisting of an artificial intelligence device controller and a control console controller.

18. The system of claim 4, wherein the electronic controller is selected from the group consisting of an artificial intelligence device controller and a control console controller.

19. A system for treating a tissue condition of a human or animal patient comprising:

an electronic acoustic pressure shock wave applicator including an acoustic pressure shock wave generation source enclosed within liquid by a coupling membrane;

an electronic controller coupled to the shock wave applicator and including a microprocessor and a microprocessor-readable data storage medium having microprocessor-executable instructions for the microprocessor to increase an initial acoustic pressure shock waves dosage based on the type of condition and the treatment area or treatment volume to an adjusted individualized acoustic pressure shock waves dosage calculated through a plurality of dosage changes to the initial shock wave dosage wherein each dosage change corresponds to an individualized patient parameter selected from the group consisting of a tissue condition state, comorbidity parameter, physical characteristic parameter and lifestyle habit parameter of the patient, wherein said electronic controller is communicatively coupled for wireless or wired communication to the acoustic pressure shock wave applicator and causes the applicator to automatically generate the adjusted individualized acoustic pressure shock waves dosage to the patient during treatment of the tissue condition; and

an electronic input device receiving data input in response to questions from a patient questionnaire and communicatively coupled for wireless or wired transmission of the input data to the electronic controller for determination of dosage changes corresponding to individualized patient parameters.

20. The system for claim 19, wherein the tissue condition is a diabetic foot ulcer.